Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
80 participants
INTERVENTIONAL
2006-12-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study the Impact of Statins in Septic Shock
NCT02681653
Statins for the Early Treatment of Sepsis
NCT00528580
Effect of Statin Therapy on Sepsis-related Mortality in Intensive Care Unit Patients
NCT06354452
Statin Therapy in the Treatment of Sepsis
NCT00676897
Simvastatin in Patients With Septic Shock
NCT00450840
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
amido pill
amido pill
one pill of amido/d by mouth for 10 days
atorvastatina
atrovastatina 80 mg/d by mouth for 10 days
atorvastatina
atorvastatina 80 mg/day by mouth for 10 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
amido pill
one pill of amido/d by mouth for 10 days
atorvastatina
atorvastatina 80 mg/day by mouth for 10 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no more than twenty four hours than diagnosis
Exclusion Criteria
* unequivocal indication for statin treatment
* active treatment with imunosuppressors drugs
* High risk of rhabdomyolysis: multiple trauma, crush injuries, baseline creatinine kinase \> three times upper limit of normal
* diagnosis of AIDS
* unable to receive enteral medications
* pregnancy
* expected survival of less than 48 hours
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Clinicas de Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hospital de Clinicas de Porto Alegre
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nadine Clausell
Role: PRINCIPAL_INVESTIGATOR
Federal University of Rio Grande do Sul - Brazil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HCPA - Clinical Hospital fo Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05589
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.